Compare ImmunityBio Inc. Common Stock (IBRX) vs iShares Self-Driving EV and Tech (IDRV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ImmunityBio Inc. Common Stock vs iShares Self-Driving EV and Tech — how do they compare? ImmunityBio Inc. Common Stock trades at $10.03 (market cap $10.51B), while iShares Self-Driving EV and Tech trades at $32.75 (market cap $264.50M). The key difference: ImmunityBio Inc. Common Stock is far larger — about 39.7× iShares Self-Driving EV and Tech's market cap, and ImmunityBio Inc. Common Stock is trading nearer its 52-week high, iShares Self-Driving EV and Tech nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 0 Days and iShares Self-Driving EV and Tech for 73 Days on average.
| IBRX | IDRV | |
|---|---|---|
Market Cap | $10.51B | $264.50M |
Volume | 10,445,785 | 48,021 |
Sector | Health | Sector/Thematic |
52-Week High | $11.55 | $45.48 |
52-Week Low | $1.98 | $32.68 |
Typical Hold Time | 0 Days | 73 Days |
Enterprise Value | $10.97B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →About iShares Self-Driving EV and Tech
IDRV invests in global companies at the forefront of self-driving and electric vehicle innovation. It provides exposure to the full EV value chain, including battery technology and autonomous systems, with top holdings like Albemarle, Rivian, and Tesla.
Read more on IDRV →
